Nanohydrogel Composite Vaccine Capable of Bypassing the Blood–Brain Barrier and Targeting Tumors for Glioblastoma Immunotherapy via Intranasal Immunization
Dawei Dai, Shuo Han, Guangming Wang, Yongming Qiu, Ang Li · 2026
Read Nanohydrogel Composite Vaccine Capable of Bypassing the Blood–Brain Barrier and Targeting Tumors for Glioblastoma Immunotherapy via Intranasal Immunization by Dawei Dai, Shuo Han, Guangming Wang, Yongming Qiu, Ang Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13611568.txt.
Description
Dawei Dai and four co-authors built a nose-delivered vaccine gel against a lethal brain tumor, in a 2026 paper. The tumor resists immune therapy for two reasons. A tight barrier guards the brain, and the tumor setting suppresses immune attack. Their vaccine uses a soft gel loaded with tumor pieces and immune boosters. A special peptide in the gel helps cross the brain barrier.
Tests in cells and animals showed strong barrier crossing and tumor targeting. In mice with brain tumors, the vaccine greatly extended survival over controls. Tumors shrank sharply by three weeks. Killer immune cells flooded the tumors, while suppressive cells fell steeply. The authors call the gel a promising route for brain tumor immune therapy. Delivery through the nose avoids surgery and needles.
Catalog record
| CREATOR | Dawei Dai, Shuo Han, Guangming Wang, Yongming Qiu, Ang Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |